Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation
Multiple myeloma is characterized by high rates of drug resistance and relapse. Here the authors utilize a functional assay to assess the ex vivo drug sensitivity of single multiple myeloma cells based on measuring the mass accumulation rate of individual cells.
Guardado en:
Autores principales: | Arif E. Cetin, Mark M. Stevens, Nicholas L. Calistri, Mariateresa Fulciniti, Selim Olcum, Robert J. Kimmerling, Nikhil C. Munshi, Scott R. Manalis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/629a770514a4473e857f4d9145de3dc2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microfluidic active loading of single cells enables analysis of complex clinical specimens
por: Nicholas L. Calistri, et al.
Publicado: (2018) -
Genomic patterns of progression in smoldering multiple myeloma
por: Niccolò Bolli, et al.
Publicado: (2018) -
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
por: Mehmet Kemal Samur, et al.
Publicado: (2021) -
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
por: Francesco Maura, et al.
Publicado: (2019) -
Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Ajai Chari, et al.
Publicado: (2010)